Literature DB >> 116086

Birthweight of infants with phenylketonuria and their unaffected siblings.

I Smith, C O Carter, O H Wolfe.   

Abstract

Entities:  

Mesh:

Year:  1978        PMID: 116086     DOI: 10.1007/bf01805681

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


× No keyword cloud information.
  5 in total

1.  Within-family standards for birth-weight.

Authors:  J M Tanner; H Lejarraga; M J Healy
Journal:  Lancet       Date:  1972-12-16       Impact factor: 79.321

2.  Birthweights in children with phenylketonuria and in their siblings.

Authors:  L F Saugstad
Journal:  Lancet       Date:  1972-04-15       Impact factor: 79.321

3.  Standards for birthweight as gestation periods from 32 to 42 weeks, allowing for maternal height and weight.

Authors:  J M Tanner; A M Thomson
Journal:  Arch Dis Child       Date:  1970-08       Impact factor: 3.791

4.  Heterozygote advantage for the phenylketonuria allele.

Authors:  L F Saugstad
Journal:  J Med Genet       Date:  1977-02       Impact factor: 6.318

5.  Birthweight of children with phenylketonuria.

Authors:  K J Rothman; S N Pueschel
Journal:  Pediatrics       Date:  1976-12       Impact factor: 7.124

  5 in total
  4 in total

1.  Birth weight in phenylketonuria.

Authors:  L I Woolf; D J Crockett
Journal:  Arch Dis Child       Date:  1995-09       Impact factor: 3.791

2.  No reduction in birth weight in phenylketonuria.

Authors:  S L Tillotson; P M Costello; I Smith
Journal:  Eur J Pediatr       Date:  1995-10       Impact factor: 3.183

3.  Impaired prenatal and postnatal growth in Dutch patients with phenylketonuria. The National PKU Steering Committee.

Authors:  P H Verkerk; F J van Spronsen; G P Smit; R C Sengers
Journal:  Arch Dis Child       Date:  1994-08       Impact factor: 3.791

4.  Cord-blood tyrosine levels in the full-term phenylketonuric fetus and the "justification hypothesis".

Authors:  C R Scriver; D E Cole; S A Houghton; H L Levy; A Grenier; C Laberge
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.